A Study of Influences of p53 Mutation, Cyclin D1 Over Expression, Ki67 Index, Mitotic Index on the Prognosis of Esophageal Squamous Cell Carcinoma

p53 변이, Cyclin D1의 과발현, Ki67 지수, 세포분열지수가 식도의 편평상피암의 예후에 미치는 영향

  • Lee Hae Won (Department of Thoracic Surgery, Korean Cancer Center Hospital) ;
  • Cho Suk Ki (Department of Thoracic and Cardiovascular Surgery, Bundang Seoul National University Hospital) ;
  • Sung Sook Whan (Department of Thoracic Cardiovascular Surgery, Bundang Seoul National University Hospital) ;
  • Lee Hyun Joo (Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine) ;
  • Kim Young Tae (Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine) ;
  • Kang Moon Chul (Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine) ;
  • Kim Joo Hyun (Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine)
  • 이해원 (원자력병원 흉부외과) ;
  • 조석기 (분당서울대병원 흉부외과) ;
  • 성숙환 (분당서울대병원 흉부외과) ;
  • 이현주 (서울대학교 의과대학 흉부외과학교실) ;
  • 김영태 (서울대학교 의과대학 흉부외과학교실) ;
  • 강문철 (서울대학교 의과대학 흉부외과학교실) ;
  • 김주현 (서울대학교 의과대학 흉부외과학교실)
  • Published : 2005.12.01

Abstract

Background: Cancer of the esophagus is one of the most malignant tumors with poor prognosis. The p53 gene alteration, over expression of Cyclin D1, and Ki67 index were thought to be the prognostic factors. However, their clinical significances in esophageal squamous cell carcinoma are controversial and p53 accumulation may not correlate with genetic mutation. The current study investigates their prognostic significance in squamous cell carcinoma of the esophagus. Material and Method: The Subjects studied were 124 esophageal squamous cell carcinoma patients who underwent esophagectomy. The mutation of p53, over expression of Cyclin D1, Ki67 labelling index, mitotic index were examined by using an immunohistochemical staining. We compared the results and investigated the correlation with the mutation of p53, overexpression of Cyclin D1, Ki67 labelling index, mitotic index and tumor size, and duration of survival. Result: There was no correlation between the results in immunohistochemical staining according to age, sex, tumor size, Iymph node status, and clinical stage of the disease. Mutant p53 protein was found in 69 cases (55.6$\%$). Median survival time was 21 months in cases with negative for mutant p53 protein and 22 months in positive cases. There was no significant difference in survival (p=0.46). Median survival time was 22 months in cases with negative for Cyclin D1 and 16 months in positive cases (p=0.18). Median and mean survival time was 22 months and 36 months when Ki67 labeling index was 40 or less (102 cases). Median and mean survival was 16 months and 23 months, when Ki67 labeling index was more than 40 (22 cases). There was significant difference in survival rate (p=0.011). Conciusion: Positivity of p53 and cyclin D1 was not useful in predicting the prognosis in our study. There was no significant correlation among mutant p53 protein accumulation, Cyclin D1 over expression, and Ki67 labeling index. However, in several studies, PCR single strand conformational polymorphism analysis of p53 showed a correlation to the prognosis. We thought that there was a significant discordance between p53 gene mutation and mutant p53 protein accumulation. When Ki67 labeling index was more than 40, prognosis was poorer, Ki67 seems to be a prognostic factor in our study. Therefore, we confirmed the possibility of using molecular markers as prognostic factors.

배경: 분자학적 표지자들과 식도암과의 관련성에 대해서 아직 뚜렷하게 밝혀진 바가 없다. 본 연구에서는 먼저 p53, Cyclin D1과 Ki67 지수 등 종양 표식자가 국내 식도암 환자에서 수술 후 얻어진 식도암 조직의 병기, 악성도, 임파선 전이 여부 등과 어떠한 관련성이 있는가를 알아보고 이를 이용해 향후 국내 식도암 환자에 대한 예후 분석 및 치료방침 결정 그리고 조기발견에 이용할 수 있는지 알아보았다. 또한 본 연구는 분자학적 표지자들의 임상적용의 기초를 마련하고자 하는 목적으로 시행하였다. 대상 및 방법: 1992년 3월부터 수술 후 조직절편이 보존된 124명의 환자를 대상으로 하였다. 조직절편의 파라핀을 제거한 뒤에 p53 변이, Cyclin D1의 과발현, Ki67 지수에 대한 면역조직화학 염색법을 시행하였으며 조직슬라이드상에서 세포분열지수를 구하였다. 이 결과와 임상적인 변수들과의 상관관계를 분석하였고, 환자의 생존 및 재발 결과와 비교하였다. 결과: 환자의 성별, 나이, 병기, 종양 크기, 타장기 전이 여부, 국소적인 재발 여부와 p53의 변이, Cyclin D1의 과발현, Ki67 지수, 세포분열 지수에 따른 통계적으로 유의한 차이는 없었다. Ki67 지수는 40 미만인 경우와 40 이상인 경우로 나누었을 경우 통계적으로 유의하게 생존기간에 있어서 차이가 나는 것으로 나타났으나(p=0.011) 다른 표지자들은 생존기간에 유의한 차이를 보이지 않았다. 결론: 높은 Ki67지수는 식도의 편평상피암의 예후에 나쁜 영향을 미치는 것으로 나타났으나 다른 표지자들은 영향을 미치지 않았다 이번의 연구를 통해 분자학적인 지표들이 임상적으로 가치 있는 인자가 될 수 있다고 판단되었다.

Keywords

References

  1. Ikeguchi M, Sakatani T, Ueta T, et al. Correlation between cathepsin D expression and p53 protein nuclear accumulationin oesophageal squamous cell carcinoma. J Clin Pathol 2002;55:121-6 https://doi.org/10.1136/mp.55.2.121
  2. Kobayashi S, Koide Y, Endo M, Isono K, Ochiai T. The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability. Am J Surg 1999;177:497-502 https://doi.org/10.1016/S0002-9610(99)00085-9
  3. Nasierowska-Guttmejer A, Szawowski A, Jastrzbska M, Jeziorski K, Radziszewski J. p53 Protein accumulation as a prognostic marker of preoperative radiotherapy and/or chemotherapy in advanced squamous cell esophageal carcinoma- preliminary report. Dis Esophagus 1999;12:128-31 https://doi.org/10.1046/j.1442-2050.1999.00030.x
  4. Monges GM, Seitz JF, Giovannini MF, Gouvernet JM, Torrente MA, Hassoun JA. Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus. Cancer Detect Prev 1996;20:63-7
  5. Ohashi K, Nemoto T, Eishi Y, Matsuno A, Nakamura K, Hirokawa K. Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in esophageal squamous cell carcinomas. Virchows Arch 1997;430:107-15 https://doi.org/10.1007/BF01008031
  6. Coggi G, Bosari S, Roncalli M, et al. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer 1997;79:425-32 https://doi.org/10.1002/(SICI)1097-0142(19970201)79:3<425::AID-CNCR1>3.0.CO;2-H
  7. Uchino S, Saito T, Inomata M, et al. Prognostic significance of the p53 mutation in esophageal cancer. Jpn J Clin Oncol 1996;26:287-92 https://doi.org/10.1093/oxfordjournals.jjco.a023234
  8. Nagasawa S, Onda M, Sasajima K, et al. Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma. J Surg Oncol 2001;78:208-14 https://doi.org/10.1002/jso.1152
  9. Itami A, Shimada Y, Watanabe G, et al. Prognostic value of p27 (Kip1) and Cyclin D1 expression in esophageal cancer. Oncology 1999;57:311-7 https://doi.org/10.1159/000012067
  10. Kohmura T, Hasegawa Y, Ogawa T, et al. Cyclin D1 and p53 overexpression predicts multiple primary malignant neoplasms of the hypopharynx and esophagus. Arch Otolaryngol Head Neck Surg 1999;125:1351-4 https://doi.org/10.1001/archotol.125.12.1351
  11. Xu M, Jin YL, Fu J, et al. The abnormal expression of retinoic acid receptor-beta, p53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. World J Gastroenterol 2002;8:200-2 https://doi.org/10.3748/wjg.v8.i2.200
  12. Kitamura K, Saeki H, Kawaguchi H, et al. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterology 2000;47:419-23
  13. Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75:423-9 https://doi.org/10.1002/1097-0142(19950115)75:2<423::AID-CNCR2820750202>3.0.CO;2-5